Papers
3
Total Citations
20
H-Index
2
About
Morgan Black’s research spans the translational frontiers of oncology and robotic surgery, with a particular focus on head and neck squamous cell carcinoma (HNSCC) and urologic oncology. Their most impactful work, a 2018 study with 15 citations, pioneered high-throughput drug testing in HNSCC, identifying agents with preferential activity in human papillomavirus (HPV)-positive versus HPV-negative cell lines. This contribution provides a critical framework for personalized therapy in a disease where HPV status dictates prognosis and treatment response. In urology, Black has advanced the evidence base for robotic partial nephrectomy, reporting on a 20-year single-institution experience (2024, 3 citations) that offers real-world outcomes for this minimally invasive approach. Their recent work on robotic sacral colpopexy using autologous fascia lata (2025, 2 citations) evaluates medium-term outcomes for pelvic organ prolapse, showcasing a commitment to refining surgical techniques. Black’s ability to bridge laboratory discovery—such as HPV-specific drug sensitivities—with clinical outcomes in robotic surgery underscores a career dedicated to improving patient care through both mechanistic insight and surgical innovation.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3